| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |